Print Email
Friday, October 15, 2021 12:00 AM

Fellowship:  T32 Clinical and Translational Cancer Control Research Training Program   Rochester, NY

Dear Colleagues:

Now in its 18th year, the NCI-funded T32 Clinical and Translational Cancer Control Research Training Program at the University of Rochester and Wilmot Cancer Institute is seeking outstanding candidates for our upcoming group of post-doctoral fellows starting in summer, 2022. Please see our new video.

Our program eagerly seeks highly motivated individuals with doctorates (Ph.D., M.D., or equivalent) who are committed to developing a successful research career in cancer control as independent investigators.

The program features exceptionally diverse research opportunities and professional guidance by several NCI-funded mentors. Core program mentors include: Drs. Michelle Janelsins, Ph.D., M.P.H., Gary Morrow, Ph.D., M.S., Karen Mustian, Ph.D., M.P.H., Supriya Mohile, M.D., M.S., Luke Peppone, Ph.D., M.P.H., Charles Kamen, Ph.D., M.P.H., Sarah Kerns, Ph.D., Eva Culakova, Ph.D., Paula Cupertino, Ph.D., and Kim Van Orden, Ph.D. An additional 18 affiliate mentors join our core mentors in providing broad multi-disciplinary mentorship experiences for trainees.

Several key training resources are offered including the University of Rochester NCI-funded Community Oncology Research Program (NCORP) Research Base and several specialty laboratories. Cancer control programmatic specialty training areas of our training program include: conduct of Phase I-III clinical trials in both academic and local and nationwide community oncology research settings, geriatric oncology, cancer care delivery research, behavioral interventions, exercise oncology, health equity, nutraceuticals, mobile health, translational science (e.g., protein biomarker, genetics, epigenetics, immunology, physiology, etc.), and biostatistics. A more detailed description of the program, description of mentors, didactic courses and other research training opportunities, and application materials can be found at:

Candidates must be US citizens or permanent residents. Candidates must have completed their doctoral training and have their degree conferred prior to starting the program. Candidates with prior post-doctoral training are also eligible. 

Two years of funding with stipends of $65,000 per year are offered along with tuition, health insurance, research support, travel to scientific meetings and a Research Assistant Professor position. Applications require three letters of recommendation, a personal statement of your research interests and how you think the program will help your research career along with your CV. Applications received on or before December 15, 2021 will receive priority for review. For questions, please email Co-Directors Drs. Janelsins and Morrow at [email protected].

Thank you for your consideration of our NCI T32 Clinical and Translational Cancer Control Research Training Program located in the beautiful Finger Lakes region of upstate New York.